• AbbVie in national product liability litigation related to its product Androgel, a testosterone replacement therapy. This litigation comprises an MDL in Chicago and additional cases in state courts in Mississippi, Illinois, Pennsylvania and Missouri.
    • Getinge AB and Atrium Medical Corporation in more than 2,400 personal injury lawsuits that have been filed involving their hernia mesh products, including an MDL in New Hampshire.
    • GlaxoSmithKline as lead national counsel in an ongoing MDL in the Southern District of Florida concerning the FDA’s market withdrawal of Zantac, an over-the-counter heartburn medication, due to concerns of alleged carcinogenicity.
    • Pfizer as National counsel in the Zoloft MDL, where hundreds of plaintiffs alleged that maternal use of Zoloft, an antidepressant, caused their children to be born with various birth defects. Dechert convinced the Court early in the litigation that the most efficient approach to the MDL would be to stage general causation ahead of other case specific issues. With that framework, Dechert successfully excluded all of plaintiffs’ general causation testimony and secured summary judgment in the entire MDL. The Third Circuit unanimously affirmed, cementing the resounding victory for Pfizer.
    • Takata Corporation in connection with civil litigation, criminal and NHTSA investigations and Congressional hearings related to airbags.